Trouble reading this email? View it in your browser
European Federation of Pharmaceutical Industries and Associations EFPIA Newsletter 23 May 2024
      News
 
  21 May 2024 Pharmaceutical trade associations welcome latest announcement of largest number of regulatory...

The WLA framework is crucial for regulatory convergence and harmonisation.

Read more →
 
 
 
      Clinical Trials Day 2024
 
  20 May 2024 Lab of the future: when science and technology meet to deliver medicines faster in Europe

As science evolves, if you're just keeping up, you're already behind the curve.

Read more →
 
 
 
  16 May 2024 Advancing Clinical Trials for European Patients

Now is the time to catalyse healthcare innovation – improving patients’ lives and restoring Europe as a powerhouse for...

Read more →
 
 
 
      Open Letter ECRD 2024

Last week, we were honored to join ECRD 2024 and sign an open letter calling on the next European leaders to:

  • Maintain health at the forefront of future policies and programmes.

  • Develop a comprehensive European Action Plan for Rare Diseases that bridges diverse policy areas and streamlines existing efforts with clear, measurable objectives.

  • Immediately address the most pressing needs of the rare disease population by integrating the actions ‘within reach’ that we have collectively identified within the work programmes of the next years.

Read and sign the open letter here.

 

 
 
 
      Events
 
 
31 MAY 2024
  IMI impact on antimicrobial resistance Online event

Combatting antimicrobial resistance: the legacy of the IMI COMBACTE projects.

Learn more →
 
 
 
04 JUN 2024
  Countdown to the EU HTA: how can we seize this opportunity to improve patient access... Online session

In January 2025, all new cancer medicines and advanced therapy medicinal products (ATMPs) will be jointly assessed at...

Learn more →
 
 
      Register for the webinar series "5 ways to reduce cancer care inequalities in Europe"

From May 27th to May 31st, 2024, CPE, EFPIA and IHE will host a series of webinars to discuss how to reduce cancer care inequalities in Europe. 

 

Schedule:
May 27 - Prevention & Early Diagnosis
May 28 - Innovative Diagnostics & Accurate Diagnosis
May 29 - Innovation in Treatment
May 30 - Survivorship
May 31 - Smoking Cessation, a step towards a cancer-free environment

 

Register now!

 

 
 
      What we are reading
Beating cancer in Europe: A health priority within our grasp 22 May 2024  (Euractiv) Read more →
Multiple Myeloma in Central Europe and the Baltics: Supporting early and equitable access to... 19 May 2024  (Economist Impact) Read more →
Industry group pushes for more progress against antimicrobial resistance 06 May 2024  (CIDRAP) Read more →
    About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

 
Tel: +32 (0)2 626 25 55
Communications@efpia.eu
in
 
EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe